MS Patients Report Excellent Compliance with Oral Prednisone for Acute Relapses

Sarah A. Morrow, Lynn McEwan, Katayoun Alikhani, Christopher Hyson, Marcelo Kremenchutzky

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2012 · 19 citations · 16 references

DOIFull text

Open access

Abstract

High dose (1,250 mg) oral prednisone is an acceptable therapy to MS patients for the treatment of acute relapses with a high rate of compliance.

References

16